FDA Approved: KUVAN — Original Application (BioMarin Pharmaceutical Inc.)

View source ↗

Summary

FDA approved Kuvan (sapropterin dihydrochloride) from BioMarin as an original application for the treatment of phenylketonuria, to improve tolerance to dietary …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Phenylketonuria

Drugs mentioned

• KUVAN (Sapropterin dihydrochloride)

Snippet

ORIG AP for KUVAN (SAPROPTERIN DIHYDROCHLORIDE)